title: [Comparison of mortality and morbidity in newborns treated with ambroxol prenatally and postnatally].
abstract: The effect of Ambroksol given pre- and postnatal on infant mortality and morbidity was performed. In particular we found a statistically significant differences in reduction of mortality in the group A treated with Ambroksol pre- and postnatal vs. group B treated only postnatal. The other parameters of morbidity had no significantly importance but sepsis, which was more often diagnosed in group A than in group B (17.5% vs. 11.1%). We connect this fact with higher frequency of PROM in the group A.
authors.affiliation: Kliniki Neonatologii Instytutu Ginekologii i Połoznictwa AM w Poznaniu.
authors.forename: S
authors.initials: S
authors.lastname: Sackey
authors.forename: J
authors.initials: J
authors.lastname: Gadzinowski
authors.forename: M
authors.initials: M
authors.lastname: Szymankiewicz
authors.forename: G H
authors.initials: GH
authors.lastname: Breborowicz
authors.forename: J
authors.initials: J
authors.lastname: Rudnicki
authors.forename: J
authors.initials: J
authors.lastname: Patalan
authors.forename: K
authors.initials: K
authors.lastname: Rózewicki
mesh_terms: D000551:Ambroxol / Q000627:therapeutic use*; D001034:Apgar Score; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy* / Q000453:epidemiology*; D011181:Postnatal Care; D011247:Pregnancy; D011295:Prenatal Care; D015996:Survival Rate
chemical_list: D000551:Ambroxol
vernacular_title: Porównanie śmiertelności i zachorowalności noworodków leczonych Ambroksolem prenatalnie i pourodzeniowo.